Lori Coward

Title: Lori Coward: Innovator in Multiple Sclerosis Research

Introduction

Lori Coward is a notable inventor based in Birmingham, AL (US). She has made significant contributions to the field of medical research, particularly in understanding multiple sclerosis. Her innovative work has led to the development of a patented method that aids in predicting the progression of this complex disease.

Latest Patents

Lori Coward holds a patent for her invention titled "P-cresol sulfate, a component of urinary myelin basic protein-like material, as a correlate of multiple sclerosis status." This invention provides a method for determining the status of a multiple sclerosis patient by measuring the amount of urinary p-cresol sulfate. It also offers a way to assess the extent of lesions in patients and monitor myelination in developing children.

Career Highlights

Lori Coward is associated with the UAB Research Foundation at the University of Alabama at Birmingham. Her work has been instrumental in advancing the understanding of multiple sclerosis and its effects on patients. With her innovative approach, she has contributed to the medical community's efforts to improve patient care and treatment options.

Collaborations

Lori has collaborated with esteemed colleagues such as John Nicholas Whitaker and Robert David Kachelhofer. These partnerships have further enriched her research and expanded the impact of her work in the field.

Conclusion

Lori Coward's contributions to multiple sclerosis research through her innovative patent demonstrate her commitment to advancing medical science. Her work not only aids in understanding the disease but also enhances the quality of life for patients.